HPV Vaccination to Prevent HIV Infection: Time for Randomized Controlled Trials
Authors:
- Maarten F. Schim van der LoeffMLMaarten F. Schim van der Loeff
- Alan G. NyitrayANAlan G. Nyitray
- Anna R. GiulianoAGAnna R. Giuliano
- 1 July 2011
- journal article
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 38 (7) , 640-643
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in WomenScience, 2010
- Weighing the gold in the gold standard: challenges in HIV prevention researchAIDS, 2010
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandNew England Journal of Medicine, 2009
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialThe Lancet, 2008
- Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trialThe Lancet, 2007
- Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trialThe Lancet, 2007
- Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 TrialPLOS Medicine, 2005
- Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trialThe Lancet, 2002
- From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infectionSexually Transmitted Infections, 1999
- Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trialThe Lancet, 1995